Consensus $6.89. The company noted that the outlook it provided in January is consistent with its new long-term growth and return targets. The company continues to expect to deliver a low-to-mid single-digit percentage increase in 2024 organic net sales versus the prior year period, with growth in reported net sales forecast to reflect negative impacts of approximately 300 basis points from currency translation and 60 basis points from the Brazil Tissue divestiture. Adjusted operating profit is still expected to grow at a high single-digit to low double-digit rate on a constant-currency basis and adjusted earnings per share are expected to grow at a high single-digit rate on a constant-currency basis versus the prior year period. Reported growth in operating profit and earnings per share are still expected to be negatively impacted by approximately 400 basis points from currency translation. This outlook reflects assumptions subject to change given the macro environment.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMB:
- Kimberly Clark Embarks on Cost-Cutting Global Transformation
- McDonald’s non-executive chairman Enrique Hernandez Jr. retires
- Ex-Dividend Date Nearing for These 10 Stocks – Week of March 4, 2024
- Kimberly-Clark assumed Buy from Neutral at Goldman Sachs
- Bad News for Kimberly Clark Stock: This New Risk Has Been Added
Questions or Comments about the article? Write to editor@tipranks.com